StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) SEC filings

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.48+0.05 (+0.78%)

Close on Nov 17, 2026Market cap $110.85MP/E –Yield –

SEC filings

12 of Atrium Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 12, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 2, 2026Nov 2, 2026SEC EDGAR
Current report8-KOct 27, 2026Oct 27, 2026SEC EDGAR
Current report8-KOct 7, 2026Oct 8, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 13, 2026SEC EDGAR
Current report8-KAug 13, 2026Aug 13, 2026SEC EDGAR
Current report8-KJul 14, 2026Jul 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Current report8-KFeb 26, 2026Feb 27, 2026SEC EDGAR
Current report8-KFeb 26, 2026Feb 26, 2026SEC EDGAR

See a number that looks wrong?